Exercising the hepatobiliary-gut axis. The impact of physical activity performance.

Emilio Molina-Molina, Raquel Lunardi Baccetto, David Q-H Wang, Ornella de Bari, Marcin Krawczyk, Piero Portincasa
Author Information
  1. Emilio Molina-Molina: Clinica Medica "A. Murri", Department of Biomedical Sciences & Human Oncology, University of Bari Medical School, Bari, Italy. ORCID
  2. Raquel Lunardi Baccetto: Clinica Medica "A. Murri", Department of Biomedical Sciences & Human Oncology, University of Bari Medical School, Bari, Italy. ORCID
  3. David Q-H Wang: Department of Medicine, Division of Gastroenterology and Liver Diseases, Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, NY, USA. ORCID
  4. Ornella de Bari: Clinica Medica "A. Murri", Department of Biomedical Sciences & Human Oncology, University of Bari Medical School, Bari, Italy. ORCID
  5. Marcin Krawczyk: Department of Medicine II, Saarland University Medical Center, Homburg, Germany. ORCID
  6. Piero Portincasa: Clinica Medica "A. Murri", Department of Biomedical Sciences & Human Oncology, University of Bari Medical School, Bari, Italy. ORCID

Abstract

BACKGROUND: Physical inactivity puts the populations at risk of several health problems, while regular physical activity brings beneficial effects on cardiovascular disease, mortality and other health outcomes, including obesity, glycaemic control and insulin resistance. The hepatobiliary tract is greatly involved in several metabolic aspects which include digestion and absorption of nutrients in concert with intestinal motility, bile acid secretion and flow across the enterohepatic circulation and intestinal microbiota. Several metabolic abnormalities, including nonalcoholic fatty liver as well as cholesterol cholelithiasis, represent two conditions explained by changes of the aforementioned pathways.
MATERIALS AND METHODS: This review defines different training modalities and discusses the effects of physical activity in two metabolic disorders, that is nonalcoholic fatty liver disease (NAFLD) and cholelithiasis. Emphasis is given to pathogenic mechanisms involving intestinal bile acids, microbiota and inflammatory status.
RESULTS: A full definition of physical activity includes the knowledge of aerobic and endurance exercise, metabolic equivalent tasks, duration, frequency and intensity, beneficial and harmful effects. Physical activity influences the hepatobiliary-gut axis at different levels and brings benefits to fat distribution, liver fat and gallbladder disease while interacting with bile acids as signalling molecules, intestinal microbiota and inflammatory changes in the body.
CONCLUSIONS: Several beneficial effects of physical activity are anticipated on metabolic disorders linking liver steatosis, gallstone disease, gut motility, enterohepatic circulation of signalling bile acids in relation to intestinal microbiota and inflammatory changes.

Keywords

References

  1. Gut. 2014 Dec;63(12):1913-20 [PMID: 25021423]
  2. Med Sci Sports Exerc. 2007 Nov;39(11):1927-32 [PMID: 17986899]
  3. Peptides. 1992 Jan-Feb;13(1):125-8 [PMID: 1320260]
  4. Med Sci Sports Exerc. 2013 Jan;45(1):186-205 [PMID: 23247672]
  5. J Hepatol. 2015 Nov;63(5):1229-37 [PMID: 26385766]
  6. J Gastroenterol Hepatol. 2005 Aug;20(8):1176-84 [PMID: 16048564]
  7. JAMA Intern Med. 2016 Aug 1;176(8):1074-82 [PMID: 27379904]
  8. Curr Gastroenterol Rep. 2004 Apr;6(2):151-62 [PMID: 15191695]
  9. Med Sci Sports Exerc. 2011 Aug;43(8):1575-81 [PMID: 21681120]
  10. Gut. 2001 Mar;48(3):435-9 [PMID: 11171839]
  11. Exerc Immunol Rev. 2015;21:70-9 [PMID: 25825908]
  12. Surg Obes Relat Dis. 2016 Dec;12(10):1838-1846 [PMID: 27576208]
  13. Front Microbiol. 2017 Sep 01;8:1687 [PMID: 28919891]
  14. J Intern Med. 2017 Apr;281(4):319-336 [PMID: 27991713]
  15. Front Immunol. 2017 Nov 02;8:1452 [PMID: 29163522]
  16. Semin Liver Dis. 2015 Aug;35(3):318-37 [PMID: 26378647]
  17. Curr Pharm Des. 2013;19(29):5270-9 [PMID: 23394095]
  18. Sports Med. 1997 Feb;23(2):106-29 [PMID: 9068095]
  19. Diabetologia. 2007 Feb;50(2):404-13 [PMID: 17149589]
  20. Front Physiol. 2017 May 19;8:319 [PMID: 28579962]
  21. Front Physiol. 2016 Feb 18;7:51 [PMID: 26924990]
  22. World J Gastroenterol. 2004 Sep 15;10(18):2711-4 [PMID: 15309724]
  23. Metab Syndr Relat Disord. 2014 Jun;12(5):290-8 [PMID: 24689911]
  24. J Clin Endocrinol Metab. 2016 Nov;101(11):4219-4228 [PMID: 27583475]
  25. PLoS One. 2014 Jun 26;9(6):e100883 [PMID: 24967665]
  26. Obes Rev. 2009 May;10(3):313-23 [PMID: 19175510]
  27. Med Sci Sports Exerc. 1999 Nov;31(11 Suppl):S663-7 [PMID: 10593542]
  28. Ann Hepatol. 2011 Oct-Dec;10(4):486-92 [PMID: 21911890]
  29. World J Cardiol. 2017 Feb 26;9(2):134-138 [PMID: 28289526]
  30. J Chin Med Assoc. 2008 Nov;71(11):551-8 [PMID: 19015052]
  31. Menopause. 2016 Aug;23(8):876-83 [PMID: 27458060]
  32. Gastroenterology. 2017 May;152(7):1679-1694.e3 [PMID: 28214524]
  33. Diabetes Care. 2014 Feb;37(2):317-24 [PMID: 24062325]
  34. Diabet Med. 2009 Mar;26(3):220-7 [PMID: 19317815]
  35. Hepatology. 2012 Jun;55(6):1738-45 [PMID: 22213436]
  36. Compr Physiol. 2013 Apr;3(2):785-97 [PMID: 23720329]
  37. J Appl Physiol (1985). 2008 Mar;104(3):761-5 [PMID: 18187606]
  38. J Sports Med Phys Fitness. 2018 Oct;58(10):1525-1536 [PMID: 28558443]
  39. Curr Opin Lipidol. 2010 Dec;21(6):507-17 [PMID: 21206340]
  40. Diabetologia. 2012 Apr;55(4):885-904 [PMID: 22278337]
  41. J Phys Act Health. 2014 May;11(4):693-8 [PMID: 23493071]
  42. Int J Sports Med. 1991 Dec;12(6):533-6 [PMID: 1665841]
  43. J Hepatol. 2016 Jul;65(1):146-181 [PMID: 27085810]
  44. Obesity (Silver Spring). 2010 Feb;18(2):384-90 [PMID: 19696755]
  45. Diabetes Obes Metab. 2012 Feb;14(2):139-48 [PMID: 21923735]
  46. PM R. 2016 Jan;8(1):28-34 [PMID: 26071652]
  47. Int J Behav Nutr Phys Act. 2017 Jun 10;14(1):75 [PMID: 28599680]
  48. Mol Med. 2007 Mar-Apr;13(3-4):178-84 [PMID: 17592552]
  49. BMC Gastroenterol. 2017 Dec 08;17(1):153 [PMID: 29221432]
  50. Oxid Med Cell Longev. 2017;2017:3831972 [PMID: 28357027]
  51. J Hum Hypertens. 2008 Oct;22(10):678-86 [PMID: 18432253]
  52. J Hepatol. 2016 Jun;64(6):1388-402 [PMID: 27062661]
  53. Ann Hepatol. 2017 Oct 28;16(Suppl. 1: s3-105.):s4-s14 [PMID: 29080336]
  54. Sports Med. 1988 Apr;5(4):248-67 [PMID: 3287548]
  55. J Endocrinol Invest. 2004 Jun;27(6):603-12 [PMID: 15717662]
  56. Gastroenterology. 2015 Aug;149(2):367-78.e5; quiz e14-5 [PMID: 25865049]
  57. J Hepatol. 2013 Sep;59(3):536-42 [PMID: 23623998]
  58. Proc Soc Exp Biol Med. 1994 Sep;206(4):409-15 [PMID: 8073050]
  59. Am J Gastroenterol. 1990 Jun;85(6):752-6 [PMID: 2353699]
  60. JAMA. 2010 Oct 27;304(16):1795-802 [PMID: 20935337]
  61. Prev Med Rep. 2016 Oct 26;4:585-590 [PMID: 27843758]
  62. Sports Health. 2012 Mar;4(2):128-38 [PMID: 23016079]
  63. Gut. 2014 Dec;63(12):1838-9 [PMID: 25021422]
  64. Diabetes. 2012 Nov;61(11):2787-95 [PMID: 22751691]
  65. Metabolism. 2017 Mar;68:119-132 [PMID: 28183444]
  66. Nat Rev Dis Primers. 2016 Apr 28;2:16024 [PMID: 27121416]
  67. Circulation. 2012 Sep 18;126(12):1436-40 [PMID: 22879367]
  68. Am J Physiol Endocrinol Metab. 2013 Jul 1;305(1):E50-8 [PMID: 23651847]
  69. Diabetes Care. 1999 May;22(5):684-91 [PMID: 10332666]
  70. Am J Physiol Gastrointest Liver Physiol. 2017 Jun 1;312(6):G550-G558 [PMID: 28360029]
  71. Sci Rep. 2017 Sep 20;7(1):11977 [PMID: 28931917]
  72. Nutrition. 2014 Jul-Aug;30(7-8):814-21 [PMID: 24984998]
  73. Expert Opin Drug Discov. 2018 Feb;13(2):193-205 [PMID: 29190166]
  74. Clin Gastroenterol Hepatol. 2016 Oct;14(10):1398-411 [PMID: 27155553]
  75. PLoS One. 2014 Nov 06;9(11):e111808 [PMID: 25375228]
  76. Am J Clin Nutr. 2004 Jul;80(1):1-2 [PMID: 15213019]
  77. Hepatology. 2016 Mar;63(3):1026-40 [PMID: 26313307]
  78. Int J Sports Med. 1995 Nov;16(8):491-7 [PMID: 8776201]
  79. Am J Physiol Endocrinol Metab. 2016 Jun 1;310(11):E982-93 [PMID: 27117007]
  80. J Hepatol. 2015 Apr;62(1 Suppl):S47-64 [PMID: 25920090]
  81. Therap Adv Gastroenterol. 2013 Jul;6(4):249-59 [PMID: 23814606]
  82. J Hepatol. 2010 Jan;52(1):112-6 [PMID: 19897272]
  83. J Gastroenterol. 2013 Apr;48(4):434-41 [PMID: 23397118]
  84. Am J Gastroenterol. 2011 May;106(5):915-22 [PMID: 21206488]
  85. Circulation. 2006 Jun 6;113(22):2642-50 [PMID: 16754812]
  86. J Pharmacol Exp Ther. 1993 Apr;265(1):321-7 [PMID: 8474015]
  87. Pediatr Res. 2014 Jun;75(6):798-802 [PMID: 24603293]
  88. Obesity (Silver Spring). 2008 Jun;16(6):1355-62 [PMID: 18421281]
  89. J Nucl Med. 1997 Nov;38(11):1824-30 [PMID: 9374365]
  90. Circulation. 2007 Jul 31;116(5):572-84 [PMID: 17638929]
  91. Appetite. 2013 Apr;63:92-104 [PMID: 23274127]
  92. Hepat Mon. 2015 Oct 10;15(10):e31434 [PMID: 26587039]
  93. J Hepatol. 2012 Jan;56(1):255-66 [PMID: 21723839]
  94. Am J Physiol Endocrinol Metab. 2011 Nov;301(5):E1033-9 [PMID: 21846904]
  95. J Gastroenterol Hepatol. 2009 Oct;24 Suppl 3:S105-18 [PMID: 19799688]
  96. World J Gastroenterol. 2014 Apr 21;20(15):4382-92 [PMID: 24764677]
  97. World J Gastroenterol. 2014 Aug 7;20(29):10128-36 [PMID: 25110440]
  98. Med Sci Sports Exerc. 2001 Jun;33(6 Suppl):S364-9; discussion S419-20 [PMID: 11427761]
  99. Ann Epidemiol. 2017 Apr;27(4):269-273.e3 [PMID: 27955793]
  100. J Nov Physiother. 2013 Feb 16;3(125): [PMID: 23667795]
  101. Am J Physiol Heart Circ Physiol. 2014 Nov 1;307(9):H1298-306 [PMID: 25193471]
  102. Sports Med. 1997 Apr;23(4):218-27 [PMID: 9160479]
  103. Ann Hepatol. 2014 Nov-Dec;13(6):810-8 [PMID: 25332268]
  104. Afr Health Sci. 2013 Sep;13(3):667-72 [PMID: 24250305]
  105. Sci Rep. 2017 Feb 22;7:43029 [PMID: 28223710]
  106. Behav Med. 1994 Summer;20(2):84-90 [PMID: 7803941]
  107. World J Gastroenterol. 2017 May 7;23(17):3150-3162 [PMID: 28533672]
  108. PLoS One. 2014 Mar 26;9(3):e92193 [PMID: 24670791]
  109. Dig Dis Sci. 2013 Aug;58(8):2383-91 [PMID: 23609794]
  110. Gut. 2009 Sep;58(9):1281-8 [PMID: 19074179]
  111. J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):191-8 [PMID: 16706832]
  112. mSystems. 2017 Aug 22;2(4): [PMID: 28845459]
  113. J Hepatol. 2017 Oct;67(4):829-846 [PMID: 28545937]
  114. Circulation. 2013 Nov 12;128(20):2259-79 [PMID: 24126387]
  115. Diabetes Obes Metab. 2017 Feb;19(2):284-289 [PMID: 27761987]
  116. Med Sci Sports Exerc. 2000 Jan;32(1):41-5 [PMID: 10647527]
  117. Int J Obes (Lond). 2016 Dec;40(12):1927-1930 [PMID: 27439593]
  118. Br J Sports Med. 2017 May;51(9):700-701 [PMID: 28077354]
  119. Hepatology. 2009 Oct;50(4):1105-12 [PMID: 19637289]
  120. J Appl Physiol (1985). 2010 Apr;108(4):769-79 [PMID: 20368384]
  121. J Appl Physiol (1985). 2011 Dec;111(6):1828-35 [PMID: 21565984]
  122. Rehabil Res Pract. 2016;2016:6209671 [PMID: 27957342]
  123. Hepatology. 2008 Dec;48(6):1791-8 [PMID: 18972405]
  124. World J Gastroenterol. 2014 Jul 28;20(28):9338-44 [PMID: 25071328]
  125. Nutrients. 2016 Jul 20;8(7): [PMID: 27447667]
  126. Public Health Rep. 1985 Mar-Apr;100(2):126-31 [PMID: 3920711]
  127. Am J Gastroenterol. 2011 Mar;106(3):460-8; quiz 469 [PMID: 21206486]
  128. Compr Physiol. 2012 Apr;2(2):1143-211 [PMID: 23798298]
  129. Ther Adv Cardiovasc Dis. 2008 Apr;2(2):115-21 [PMID: 19124415]
  130. Hepatology. 2010 Jan;51(1):121-9 [PMID: 19827166]
  131. Lancet. 2006 Jul 15;368(9531):230-9 [PMID: 16844493]
  132. J Hepatol. 2013 Jul;59(1):138-43 [PMID: 23485520]
  133. Obesity (Silver Spring). 2008 Oct;16(10):2281-8 [PMID: 18719669]
  134. Diabetologia. 2010 Apr;53(4):624-31 [PMID: 20052455]
  135. Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G874-83 [PMID: 21350190]
  136. Int J Sports Med. 1994 Oct;15 Suppl 3:S179-83 [PMID: 7883401]
  137. Med Sci Sports Exerc. 2010 Nov;42(11):1973-80 [PMID: 20351587]
  138. Nature. 2013 Aug 29;500(7464):541-6 [PMID: 23985870]
  139. J Gastroenterol Hepatol. 2015 Jan;30(1):139-46 [PMID: 25040896]
  140. J Clin Endocrinol Metab. 2005 Jun;90(6):3191-6 [PMID: 15769987]
  141. Diabetes Care. 2010 Oct;33(10):2156-63 [PMID: 20664019]
  142. Am J Hypertens. 2007 Jun;20(6):608-15 [PMID: 17531916]
  143. Am J Gastroenterol. 2008 Sep;103(9):2239-47 [PMID: 18637096]
  144. Eur Rev Med Pharmacol Sci. 2016 Dec;20(24):5081-5097 [PMID: 28051263]
  145. Br J Surg. 2016 Sep;103(10):1350-7 [PMID: 27220492]
  146. Int J Obes (Lond). 2005 Oct;29(10):1259-66 [PMID: 15925951]
  147. Gastroenterology. 2012 Jun;142(7):1592-609 [PMID: 22656328]
  148. J Phys Act Health. 2016 Jul;13(7):788-95 [PMID: 26901710]
  149. Clin Gastroenterol Hepatol. 2017 Jan;15(1):96-102.e3 [PMID: 27521509]
  150. J Hepatol. 2017 Jan;66(1):142-152 [PMID: 27639843]
  151. Eur J Gastroenterol Hepatol. 2010 Aug;22(8):983-8 [PMID: 20130468]
  152. Drug Metab Dispos. 1994 Jul-Aug;22(4):537-43 [PMID: 7956727]
  153. Am J Physiol Endocrinol Metab. 2013 Nov 15;305(10):E1222-9 [PMID: 24045865]
  154. J Hepatol. 2012 Jul;57(1):157-66 [PMID: 22414768]
  155. Health Promot Perspect. 2011 Dec 20;1(2):147-54 [PMID: 24688911]
  156. J Hepatol. 2016 Oct;65(4):671-673 [PMID: 27392426]
  157. Obesity (Silver Spring). 2009 Dec;17(12):2162-8 [PMID: 19390517]
  158. Issues Ment Health Nurs. 2011;32(7):476-8 [PMID: 21736472]
  159. Clin Sci (Lond). 2016 Jan;130(2):93-104 [PMID: 26424731]
  160. BMC Public Health. 2012 Aug 28;12:704 [PMID: 23006411]
  161. Gut. 2011 Sep;60(9):1278-83 [PMID: 21708823]
  162. World J Gastroenterol. 2008 Mar 14;14(10):1598-602 [PMID: 18330955]
  163. Endocrinology. 2015 Nov;156(11):3961-70 [PMID: 26280129]
  164. J Appl Physiol (1985). 2012 Jul;113(1):1-6 [PMID: 22582214]
  165. J Acad Nutr Diet. 2014 Aug;114(8):1181-94 [PMID: 24631112]
  166. PLoS One. 2014 Aug 20;9(8):e105583 [PMID: 25140521]
  167. Atherosclerosis. 2011 Oct;218(2):323-9 [PMID: 21802084]
  168. Clin Sci (Lond). 2015 Dec;129(12):1097-105 [PMID: 26265792]
  169. BMC Womens Health. 2002;2(1):3 [PMID: 11846892]
  170. N Engl J Med. 2010 Sep 30;363(14):1341-50 [PMID: 20879883]
  171. Oncotarget. 2017 Apr 18;8(32):52775-52782 [PMID: 28881769]
  172. Hepatology. 2013 Oct;58(4):1287-95 [PMID: 23504926]
  173. Okla Nurse. 2008 Dec-2009 Feb;53(4):25 [PMID: 19090067]
  174. Med Sci Sports Exerc. 2007 Aug;39(8):1423-34 [PMID: 17762377]
  175. JAMA. 2009 May 20;301(19):2024-35 [PMID: 19454641]
  176. PLoS One. 2013 May 28;8(5):e65465 [PMID: 23724144]
  177. Br J Sports Med. 1998 Jun;32(2):107-10 [PMID: 9631215]
  178. J Hepatol. 2015 Jul;63(1):174-82 [PMID: 25863524]
  179. Hepatology. 2009 Jul;50(1):68-76 [PMID: 19444870]
  180. Int J Obes (Lond). 2014 Jul;38(7):950-3 [PMID: 24451187]
  181. Eur J Epidemiol. 2013 Jan;28(1):55-66 [PMID: 23354983]
  182. Clin Cardiol. 1990 Aug;13(8):555-65 [PMID: 2204507]
  183. Br J Sports Med. 1987 Sep;21(3):107-14 [PMID: 3676635]
  184. Sports Med. 2015 Sep;45(9):1295-1309 [PMID: 26068960]
  185. World J Gastroenterol. 2015 May 28;21(20):6287-95 [PMID: 26034364]

Grants

  1. R01 DK114516/NIDDK NIH HHS

MeSH Term

Adult
Aged
Bile Acids and Salts
Biliary Tract
Cholecystitis
Cholelithiasis
Exercise
Female
Healthy Lifestyle
Humans
Male
Microbiota
Middle Aged
Non-alcoholic Fatty Liver Disease

Chemicals

Bile Acids and Salts

Word Cloud

Created with Highcharts 10.0.0activitydiseasebilephysicalmetabolicintestinalmicrobiotalivereffectsacidsbeneficialnonalcoholicfattychangesinflammatoryPhysicalseveralhealthbringsincludingmotilityacidenterohepaticcirculationSeveralcholelithiasistwodifferentdisordershepatobiliary-gutaxisfatsignallinggallstonegutBACKGROUND:inactivityputspopulationsriskproblemsregularcardiovascularmortalityoutcomesobesityglycaemiccontrolinsulinresistancehepatobiliarytractgreatlyinvolvedaspectsincludedigestionabsorptionnutrientsconcertsecretionflowacrossabnormalitieswellcholesterolrepresentconditionsexplainedaforementionedpathwaysMATERIALSANDMETHODS:reviewdefinestrainingmodalitiesdiscussesNAFLDEmphasisgivenpathogenicmechanismsinvolvingstatusRESULTS:fulldefinitionincludesknowledgeaerobicenduranceexerciseequivalenttasksdurationfrequencyintensityharmfulinfluenceslevelsbenefitsdistributiongallbladderinteractingmoleculesbodyCONCLUSIONS:anticipatedlinkingsteatosisrelationExercisingimpactperformanceGprotein-coupledreceptor-1farnesoidXreceptor

Similar Articles

Cited By